ecancer

Results of orteronel plus prednisone in the TAK-700 trial on mCRPC

Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA

31 Jan 2014

Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA

31 Jan 2014

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland

10 Jan 2014

Predictors of response to mCRPC therapy: where do we stand?

Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands

10 Jan 2014

Managing mCRPC in daily practice: a pragmatic approach

Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK

10 Jan 2014

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion

J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle

10 Jan 2014

Aspirin trialled for breast cancer recurrence prevention

Dr Alistair Ring - Brighton and Sussex Medical School, UK

20 Dec 2013

Drop in breast cancer mortality in developed countries varies

Dr Donald Berry - MD Anderson Cancer Center, Houston, USA

19 Dec 2013

Breast cancer psychosocial and survivorship issues: are we doing better?

Dr Lesley Fallowfield - University of Sussex, Brighton, UK

19 Dec 2013

Careers in translational research

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA

19 Dec 2013

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

18 Dec 2013

Benefit of breast cancer screening more consistent across studies than previously understood

Dr Robert Smith - American Cancer Society, Atlanta, USA

16 Dec 2013

More from ecancer